US Patent 7504409 Mucin synthesis inhibitors
Patent 7504409 was granted and assigned to Genaera on March, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+385 characters)
Article
Patent abstract
The claimed invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infectious diseases.
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07504409 Mucin synthesis inhibitors US Patent 7504409 Mucin synthesis inhibitors
Infobox
Patent Number
0750440900
Patent Number
750440900
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075044090
Date of Patent
March 17, 2009
0Patent Application Number
108383380
Date Filed
May 5, 2004
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075044090
Date of Patent
March 17, 2009
0Patent Application Number
108383380
Date Filed
May 5, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07504409 Mucin synthesis inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07504409
Date of patent
March 17, 2009
Patent application number
10838338
Date Filed
May 5, 2004
Patent primary examiner
Find more entities like US Patent 7504409 Mucin synthesis inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
